National Cancer Institute; Notice of Meeting, 44577 [2013-17718]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 142 / Wednesday, July 24, 2013 / Notices
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Reducing the Duration of Untreated
Psychosis.
Date: August 9, 2013.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Karen Gavin-Evans, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Boulevard, Room 6153, MSC
9606, Bethesda, MD 20892, 301–451–2356,
gavinevanskm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
Dated: July 17, 2013.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–17693 Filed 7–23–13; 8:45 am]
BILLING CODE 4140–01–P
Dated: July 18, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2013–17718 Filed 7–23–13; 8:45 am]
National Cancer Institute; Notice of
Meeting
BILLING CODE 4140–01–P
sroberts on DSK5SPTVN1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Board of
Scientific Advisors ad hoc
Subcommittee on HIV and AIDS
Malignancy.
The meeting will be held via
teleconference and is open to the public.
Individuals who need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting.
Name of Committee: National Cancer
Institute Board of Scientific Advisors ad hoc
Subcommittee on HIV and AIDS Malignancy.
Date: August 8, 2013.
Time: 10:30 a.m. to 12:00 p.m.
Agenda: Discussion of HIV and AIDS
Malignancy priorities.
Place: National Cancer Institute, NIH,
Building 10, Room 10S255, 10 Center Drive,
Bethesda, MD 20892–1868, Telephone
Number: 866–492–1791.
VerDate Mar<15>2010
16:35 Jul 23, 2013
Jkt 229001
Contact Person: Robert Yarchoan, MD,
Director, HIV/AIDS Management Branch,
NIH/NCI, Building 10, Room 10S255, 10
Center Drive, Bethesda, MD 20892–1868,
301–496–0328, yarchoan@helix.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/bsa/bsa.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
Senior Executive Service Performance
Review Board
Office of the Secretary, DHS.
Notice of Federal Register.
AGENCY:
ACTION:
This notice announces the
appointment of the members of the
Senior Executive Service Performance
Review Boards for the Department of
Homeland Security. The purpose of the
Performance Review Board is to view
and make recommendations concerning
proposed performance appraisals,
ratings, bonuses, pay adjustments, and
other appropriate personnel actions for
incumbents of Senior Executive Service,
Senior Level and Senior Professional
positions of the Department.
DATES: Effective Dates: This Notice is
effective July 24, 2013.
SUMMARY:
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
44577
FOR FURTHER INFORMATION CONTACT:
Elizabeth Haefeli, Office of the Chief
Human Capital Officer, telephone (202)
357–8164.
SUPPLEMENTARY INFORMATION: Each
federal agency is required to establish
one or more performance review boards
(PRB) to make recommendations, as
necessary, in regard to the performance
of senior executives within the agency.
5 U.S.C. 4314(c). This notice announces
the appointment of the members of the
PRB for the Department of Homeland
Security (DHS). The purpose of the PRB
is to review and make recommendations
concerning proposed performance
appraisals, ratings, bonuses, pay
adjustments, and other appropriate
personnel actions for incumbents of SES
positions within DHS.
The Board shall consist of at least
three members. In the case of an
appraisal of a career appointee, more
than half of the members shall consist
of career appointees. Composition of the
specific PRBs will be determined on an
ad hoc basis from among the individuals
listed below:
Alles, Randolph D.
Amparo, Alexis
Anderson, Penny
Anderson, Rose J.
Andrews, John
Armstrong, Charles R.
Armstrong, Sue
Ayala, Janice
Baer, Thomas
Baran, Kathy
Barber, Delores
Baroukh, Nader
Barrett, Lawrence
Barrows, Angela
Bartoldus, Charles
Batkin, Joshua C.
Bauhs, Kimberlyn J.
Beagles, James
Beckham, Steward D.
Beers, Rand
Benda, Francis
Bersin, Alan
Bester, Margot
Bibo, David R.
Borkowski, Mark S.
Borras, Rafael
Bourbeau, Sharie
Boyce, Carla J.
Boyce, Maria Luisa
Boyd, David
Braccio, Dominick D
Bray, Robert S.
Breor, Scott
Brinsfield, Kathryn
Brooks, Vicki
Brown, Dallas
Brown, Meddie
Brundage, William
Brzymialkiewicz, Caryl
Buckingham, Patricia A.
E:\FR\FM\24JYN1.SGM
24JYN1
]]>Agencies
[Federal Register Volume 78, Number 142 (Wednesday, July 24, 2013)]
[Notices]
[Page 44577]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-17718]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Cancer Institute Board of Scientific Advisors ad hoc
Subcommittee on HIV and AIDS Malignancy.
The meeting will be held via teleconference and is open to the
public. Individuals who need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting.
Name of Committee: National Cancer Institute Board of Scientific
Advisors ad hoc Subcommittee on HIV and AIDS Malignancy.
Date: August 8, 2013.
Time: 10:30 a.m. to 12:00 p.m.
Agenda: Discussion of HIV and AIDS Malignancy priorities.
Place: National Cancer Institute, NIH, Building 10, Room 10S255,
10 Center Drive, Bethesda, MD 20892-1868, Telephone Number: 866-492-
1791.
Contact Person: Robert Yarchoan, MD, Director, HIV/AIDS
Management Branch, NIH/NCI, Building 10, Room 10S255, 10 Center
Drive, Bethesda, MD 20892-1868, 301-496-0328,
yarchoan@helix.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/bsa/bsa.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: July 18, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-17718 Filed 7-23-13; 8:45 am]
BILLING CODE 4140-01-P
